Heel spurs and plantar fasciitis represent one of the most common causes of heel pain — up to 10% of the population experiences this problem. The term "heel spur" refers to a bony growth on the calcaneal undersurface, but in most cases the pain source is not the spur itself but inflammation and degeneration of the plantar fascia at its calcaneal attachment — plantar fasciitis. A posterior heel spur (Haglund's deformity) is also recognized — a bony prominence at the Achilles tendon attachment. Treatment in Germany includes shockwave therapy, orthopedic correction, and innovative MIBRAR® therapy for damaged fascia regeneration.
The plantar fascia is a dense connective tissue band stretching from the calcaneal tuberosity to the toe bases. It supports the longitudinal arch and plays a key role in walking biomechanics — with each step the fascia stretches and contracts, acting as a "spring." In chronic overload at the fascia-bone attachment, microtears and collagen degeneration develop — the same process as in tendinopathy. The body attempts to "strengthen" this site by forming a bony growth — the spur. However, the pain source is not the spur (present in 15–25% of asymptomatic people!) but the fascia degeneration and surrounding tissue changes.
Posterior heel spur (Haglund's deformity) is a prominence at the upper-posterior calcaneus causing retrocalcaneal bursitis and Achilles tendon irritation, often provoked by rigid shoe counters.
Plantar fasciitis develops from chronic fascia overload. Excess weight increases fascia loading with every step. Flatfoot (pronation) and high arch (cavus foot) disrupt load distribution. Prolonged standing affects salespeople, hairdressers, and surgeons. Runners face risk especially when increasing distance or changing surfaces. Shortened calf muscle and Achilles tendon (common in women who have worn heels long-term) increases fascia tension. Peak age is 40–60 years, associated with decreasing heel fat pad and reduced fascia elasticity.
The hallmark symptom is "start-up pain" — sharp, stabbing heel pain with the first steps after sleep or prolonged sitting. Patients describe feeling a "nail in the heel" or "walking on broken glass." After several minutes of walking, pain typically decreases as the fascia "warms up" and stretches. However, by evening after prolonged loading, pain may return. Pain localizes strictly to the inner-inferior heel surface at the fascia-calcaneal attachment. With posterior spur (Haglund), pain is at the back of the heel, worsening with rigid-counter shoes. As the condition progresses, pain becomes constant and the patient begins limping, shifting weight to the outer foot edge — potentially causing knee and hip pain.
Plantar fasciitis is diagnosed clinically. Point tenderness over the medial calcaneal tuberosity and pain worsening with passive toe extension (windlass test stretching the fascia) are characteristic. Lateral foot radiography may show a spur but its presence or absence doesn't define the diagnosis. Foot ultrasound is informative — fascia thickening >4 mm at attachment, hypoechogenicity, and Doppler neovascularization. MRI excludes other heel pain causes: calcaneal stress fracture, osteonecrosis, Baxter's nerve neuropathy, and tarsal tunnel syndrome.
Good news: 90% of patients recover with conservative treatment, though it may take 6–12 months. Stretching is the most effective evidence-based method — plantar fascia and calf muscle stretches performed 3 times daily for 5 minutes (standing on a step edge slowly lowering the heel, rolling a frozen bottle underfoot, stretching the fascia before getting out of bed by pulling toes toward you). Orthopedic insoles with soft heel cushions and longitudinal arch support unload the fascia attachment. Night splints maintain dorsiflexion during sleep, preventing fascia shortening and reducing "start-up pain."
Shockwave therapy (ESWT) has proven effectiveness for chronic plantar fasciitis (>3 months) — shockwave impulses stimulate fascia tissue regeneration and destroy calcifications in 3–5 sessions at weekly intervals with 60–80% success. NSAIDs are used briefly for acute pain. Corticosteroid injection provides quick but short-term effect — limited to 1–2 injections as cortisone weakens the fascia and may cause complete rupture plus heel fat pad atrophy.
Heel spur and plantar fasciitis (Fersensporn und Haglundferse) are included in the indications for MIBRAR® technology — the optimal solution for this condition, regenerating damaged fascia without cortisone or surgery.
The plantar fascia in chronic fasciitis undergoes the same degenerative process as tendons in tendinopathy — collagen disorganization, microtears, and fibrosis. ARC containing mesenchymal stem cells and growth factors is delivered precisely into the fascia damage zone under Sono Control Arm™ guidance (0.1 mm precision). Growth factors stimulate normal type I collagen synthesis replacing degenerated type III. Anti-inflammatory ARC factors eliminate chronic inflammation without cortisone — not weakening the fascia or fat pad.
For posterior heel spur (Haglund), ARC is transplanted into the retrocalcaneal bursa and Achilles tendon attachment — simultaneously treating bursitis and Achilles tendinopathy. The procedure is outpatient without anesthesia. CGF method (Medifuge MF 200) + LIPOGEMS® ensure maximum regenerative factor concentration. Results assessed at 8–12 weeks.
Surgery is indicated in only 5–10% of patients after all conservative methods fail for 12 months. Endoscopic plantar fasciotomy partially releases the fascia through two 3 mm punctures — immediate pain relief in 85–90%, though fascia weakening may cause arch flattening, so the method is used cautiously. Haglund deformity resection removes the posterior calcaneal bone prominence endoscopically or through a minimal incision, eliminating bone-bursa-tendon conflict. Baxter's nerve neurolysis releases the first branch of the lateral plantar nerve, whose entrapment can mimic or accompany plantar fasciitis.
| Service | Price, € | Note |
|---|---|---|
| Diagnostics (ultrasound + X-ray + exam) | 1,500–2,500 | 1 day |
| Shockwave therapy (3–5 sessions) | 800–2,000 | outpatient |
| MIBRAR® therapy | on request | outpatient |
| Endoscopic fasciotomy | 3,500–6,000 | outpatient |
| Haglund deformity resection | 4,000–7,000 | outpatient / 1 day |
All treatment prices in Germany.
German foot orthopedists use the full spectrum of evidence-based methods from shockwave therapy to MIBRAR® fascia regeneration. Precise pain cause diagnosis (fasciitis? Baxter's nerve? stress fracture?) determines the correct approach. MIBRAR® therapy ensures fascia regeneration without cortisone and without rupture risk. Minimally invasive surgery when needed. Treatment at world-class clinics with multilingual assistance.
"Start-up" heel pain warrants specialist attention — contact us for the optimal treatment program in Germany.
Or send us a message:
